Clinical Trial Update: Acute Labetalol Use in Preeclampsia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on acute labetalol use in preeclampsia with severe features has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia with Severe Features

Drugs mentioned

• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Albany Medical College | Conditions: Preeclampsia With Severe Features | Phase 4 | Status: TERMINATED